What is Prostatic Artery Embolization (PAE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Prostatic Artery Embolization (PAE)?

PAE is a minimally invasive radiological procedure performed under local anesthesia that reduces prostatic blood flow through selective embolization of prostatic vessels using permanent embolic agents (typically microparticles 100-500 µm), aimed at treating moderate-to-severe lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). 1

Mechanism of Action

PAE works through a dual mechanism:

  • Induces ischemic necrosis of hyperplastic prostatic tissue, leading to prostate volume reduction
  • Decreases neuromuscular tone, addressing both static (anatomical) and dynamic (functional) components of bladder outlet obstruction 2

The procedure targets the prostatic arteries bilaterally through catheter-based delivery of embolic material, causing controlled tissue infarction specifically within the transitional zone where BPH develops 1, 3.

Technical Approach

Access route: Can be performed via femoral or radial artery approach, with radial access generally preferred by patients though anatomy should guide selection 4

Embolic agents: Non-resorbable particles (100-500 µm) are standard; liquid embolics (e.g., Glubran) are used in select centers but require additional validation 5

Imaging guidance: Advanced techniques including cone-beam CT help identify prostatic arteries and avoid non-target embolization, though this increases radiation exposure 1, 4

Clinical Positioning and Outcomes

According to the 2026 European Association of Urology Guidelines, PAE should be offered to men with moderate-to-severe LUTS/BPH who wish to consider minimally invasive options and accept less-optimal outcomes compared with TURP (weak recommendation). 1

Critical caveat: PAE must only be performed in units where urologists work collaboratively with trained interventional radiologists for patient selection and follow-up (strong recommendation). 1

Comparative Effectiveness

Versus TURP (gold standard):

  • Symptom improvements occur but are inferior to TURP in functional outcomes 1, 6
  • Higher retreatment rates than TURP 1, 6
  • Lower blood loss, shorter catheterization and hospitalization times 6
  • Better preservation of antegrade ejaculation 6

Versus medical management: PAE demonstrates clear superiority over combined medical therapy in quality of life, IPSS scores, and erectile function 7

Patient Selection Criteria

Ideal candidates:

  • Men seeking minimally invasive alternatives to surgery
  • Patients with large prostate volumes
  • Those with significant comorbidities or on anticoagulation 5
  • Men prioritizing preservation of ejaculatory function
  • Patients willing to accept higher retreatment probability

Important exclusion consideration: Patients with catheter-dependent urinary retention should preferentially receive resective technologies, not PAE 7

Safety Profile and Limitations

Unique consideration: PAE is the only BPH treatment requiring radiation exposure to the patient 7

Common adverse events:

  • Post-embolization syndrome (pain, dysuria)
  • Hematuria
  • Urinary tract infection
  • Transient urinary symptoms 1

Retreatment rates: Significantly higher than ablative surgical techniques, which must be discussed during patient counseling 1, 5

Current Guideline Status

PAE remains under investigation according to both EAU and AUA guidelines 1. The 2026 AUA Guidelines now include PAE as a viable option for managing BPH-related LUTS, representing growing acceptance 3.

The procedure has matured from experimental to an evidence-based treatment option, though it occupies a specific niche rather than replacing standard surgical approaches. Success depends heavily on operator expertise, appropriate patient selection through multidisciplinary evaluation, and realistic patient expectations regarding outcomes and potential need for retreatment 3, 5, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.